trending Market Intelligence /marketintelligence/en/news-insights/trending/DR4oyLkJE1w4BeZqzIG0FQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Biotechnology company Inscripta raises $125M in series D round

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive


Biotechnology company Inscripta raises $125M in series D round

Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.

New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.

Inscripta has now raised a total of $259.5 million.

Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.